Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	NID2 HSPG2 SPARC LAMB2 SSPOP THBS2 THBS3 MUC2 MUC5AC	4.23e-06	188	131	9	GO:0005201
GeneOntologyCellularComponent	extracellular matrix	NID2 HSPG2 SFRP1 SPARC MMP23B LAMB2 SSPOP NTN4 THBS2 THBS3 OTOGL GLG1 MUC2 MUC5AC	7.08e-05	656	132	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	NID2 HSPG2 SFRP1 SPARC MMP23B LAMB2 SSPOP NTN4 THBS2 THBS3 OTOGL GLG1 MUC2 MUC5AC	7.32e-05	658	132	14	GO:0030312
GeneOntologyCellularComponent	mucus layer	MUC2 MUC5AC	1.18e-04	3	132	2	GO:0070701
GeneOntologyCellularComponent	basement membrane	NID2 HSPG2 SPARC LAMB2 NTN4 THBS2	1.26e-04	122	132	6	GO:0005604
GeneOntologyCellularComponent	collagen-containing extracellular matrix	NID2 HSPG2 SFRP1 SPARC MMP23B LAMB2 SSPOP NTN4 THBS2 THBS3 MUC2	5.49e-04	530	132	11	GO:0062023
GeneOntologyCellularComponent	multivesicular body, internal vesicle	LRRK2 EGFR	5.84e-04	6	132	2	GO:0097487
GeneOntologyCellularComponent	microtubule organizing center	CCDC170 TRAF5 HIPK1 BRSK2 KAT2A CEP350 TBCCD1 TMUB1 PJA2 RAB34 GLG1 NLRC5 CCDC120 TNKS2 CAMSAP1	7.03e-04	919	132	15	GO:0005815
HumanPheno	Horizontal eyebrow	HSPG2 MMP23B CASZ1 EGFR PRDM16	1.84e-05	34	51	5	HP:0011228
HumanPheno	Bifid ribs	HSPG2 MMP23B CASZ1 PRDM16	1.93e-05	17	51	4	HP:0000892
HumanPheno	Neuroblastoma	HSPG2 MMP23B CASZ1 NF1 PRDM16 ALK	2.72e-05	61	51	6	HP:0003006
HumanPheno	Neuroblastic tumor	HSPG2 MMP23B CASZ1 NF1 PRDM16 ALK	2.72e-05	61	51	6	HP:0004376
HumanPheno	Peripheral primitive neuroectodermal neoplasm	HSPG2 MMP23B CASZ1 NF1 PRDM16 ALK	2.99e-05	62	51	6	HP:0030067
HumanPheno	Neuroepithelial neoplasm	HSPG2 ERBB2 MMP23B CASZ1 NF1 PRDM16 ALK	3.02e-05	92	51	7	HP:0030063
HumanPheno	Neuroectodermal neoplasm	HSPG2 ERBB2 MMP23B CASZ1 NF1 PRDM16 ALK	3.47e-05	94	51	7	HP:0030061
HumanPheno	Nervous tissue neoplasm	HSPG2 ERBB2 MMP23B CASZ1 NF1 PRDM16 ALK	3.47e-05	94	51	7	HP:0030060
HumanPheno	Primitive neuroectodermal tumor	HSPG2 MMP23B CASZ1 NF1 PRDM16 ALK	4.67e-05	67	51	6	HP:0030065
HumanPheno	Aortic arch aneurysm	HSPG2 MMP23B CASZ1 PRDM16 SMAD6	4.70e-05	41	51	5	HP:0005113
HumanPheno	Malignant neoplasm of the central nervous system	HSPG2 ERBB2 MMP23B CASZ1 NF1 PRDM16 ALK	4.86e-05	99	51	7	HP:0100836
HumanPheno	Rib fusion	HSPG2 MMP23B CASZ1 CTBP1 PRDM16	1.02e-04	48	51	5	HP:0000902
HumanPheno	Annular pancreas	HSPG2 MMP23B CASZ1 PRDM16	1.13e-04	26	51	4	HP:0001734
HumanPheno	Abnormal eyebrow morphology	RAG2 HSPG2 TRPS1 HECTD4 MMP23B CASZ1 RUSC2 ZNF711 NF1 RAB34 MEGF8 EGFR NFIB PI4KA CTBP1 PRDM16 ALOX12B	1.76e-04	674	51	17	HP:0000534
HumanPheno	Abnormal hair quantity	RAG2 HSPG2 ERCC4 TRAIP TRPS1 HECTD4 MMP23B CASZ1 MAP3K1 RUSC2 ZNF711 NF1 RAB34 ZNRF3 PI4KA DOCK6 USP48 PRDM16 ALK ALOX12B	1.81e-04	888	51	20	HP:0011362
HumanPheno	Abnormal hair pattern	HSPG2 TRAIP HECTD4 MMP23B CASZ1 MAP3K1 RUSC2 ZNF711 NF1 RAB34 MEGF8 ZNRF3 CTBP1 DOCK6 USP48 PRDM16 ALK	1.83e-04	676	51	17	HP:0010720
HumanPheno	Hypertrichosis	HSPG2 TRAIP HECTD4 MMP23B CASZ1 MAP3K1 RUSC2 ZNF711 RAB34 ZNRF3 USP48 PRDM16 ALK	1.98e-04	425	51	13	HP:0000998
Domain	Growth_fac_rcpt_	PCSK5 NID2 HSPG2 ERBB2 LAMB2 FBXL19 STAB1 NTN4 THBS3 SCUBE1 MEGF8 EGFR SLIT3	5.38e-11	156	128	13	IPR009030
Domain	ZINC_FINGER_C2H2_2	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF280B ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	2.64e-09	775	128	23	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF280B ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	2.78e-09	777	128	23	PS00028
Domain	Znf_C2H2-like	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF280B ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	4.39e-09	796	128	23	IPR015880
Domain	Znf_C2H2	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF280B ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	5.42e-09	805	128	23	IPR007087
Domain	ZnF_C2H2	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF280B ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	5.82e-09	808	128	23	SM00355
Domain	zf-C2H2	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	9.91e-09	693	128	21	PF00096
Domain	EGF_dom	NID2 STAB1 THBS2 SCUBE1 MEGF8	1.07e-08	12	128	5	IPR024731
Domain	EGF_3	NID2 STAB1 THBS2 SCUBE1 MEGF8	1.07e-08	12	128	5	PF12947
Domain	EGF_Lam	HSPG2 LAMB2 STAB1 NTN4 MEGF8 MEGF10	1.27e-07	35	128	6	SM00180
Domain	Laminin_EGF	HSPG2 LAMB2 STAB1 NTN4 MEGF8 MEGF10	1.27e-07	35	128	6	PF00053
Domain	EGF-like_dom	PCSK5 NID2 HSPG2 LAMB2 ADAM12 STAB1 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MEGF10	1.46e-07	249	128	12	IPR000742
Domain	EGF_1	HSPG2 LAMB2 ADAM12 SSPOP STAB1 NTN4 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MEGF10	1.89e-07	255	128	12	PS00022
Domain	Laminin_EGF	HSPG2 LAMB2 STAB1 NTN4 MEGF8 MEGF10	2.12e-07	38	128	6	IPR002049
Domain	EGF-like_CS	NID2 HSPG2 LAMB2 ADAM12 STAB1 NTN4 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MEGF10	2.43e-07	261	128	12	IPR013032
Domain	Znf_C2H2/integrase_DNA-bd	ZNF131 ZNF142 ZFAT ZNF366 MAZ ZNF57 ZNF317 ZNF251 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16 ZNF687	2.62e-07	694	128	19	IPR013087
Domain	EGF_2	NID2 HSPG2 LAMB2 ADAM12 SSPOP STAB1 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MEGF10	2.86e-07	265	128	12	PS01186
Domain	EGF	PCSK5 NID2 HSPG2 LAMB2 STAB1 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MEGF10	6.62e-07	235	128	11	SM00181
Domain	EGF_3	NID2 HSPG2 ADAM12 SSPOP STAB1 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MEGF10	6.62e-07	235	128	11	PS50026
Domain	-	ZNF131 ZNF142 ZFAT ZNF366 MAZ ZNF57 ZNF317 ZNF251 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16	8.88e-07	679	128	18	3.30.160.60
Domain	EGF_LAM_2	HSPG2 LAMB2 STAB1 NTN4 MEGF8	1.74e-06	30	128	5	PS50027
Domain	EGF_LAM_1	HSPG2 LAMB2 STAB1 NTN4 MEGF8	1.74e-06	30	128	5	PS01248
Domain	EGF_CA	NID2 HSPG2 STAB1 THBS2 THBS3 SCUBE1 MEGF8 SLIT3	1.96e-06	122	128	8	SM00179
Domain	EGF-like_Ca-bd_dom	NID2 HSPG2 STAB1 THBS2 THBS3 SCUBE1 MEGF8 SLIT3	2.21e-06	124	128	8	IPR001881
Domain	CTCK_1	SSPOP SLIT3 MUC2 MUC5AC	5.98e-06	18	128	4	PS01185
Domain	GF_recep_IV	PCSK5 ERBB2 EGFR	6.19e-06	6	128	3	PF14843
Domain	GF_recep_IV	PCSK5 ERBB2 EGFR	6.19e-06	6	128	3	IPR032778
Domain	-	HSPG2 SSPOP MAMDC4 NETO1 ALK	1.53e-05	46	128	5	4.10.400.10
Domain	LDLRA_1	HSPG2 SSPOP MAMDC4 NETO1 ALK	1.89e-05	48	128	5	PS01209
Domain	LDrepeatLR_classA_rpt	HSPG2 SSPOP MAMDC4 NETO1 ALK	2.09e-05	49	128	5	IPR002172
Domain	LDLa	HSPG2 SSPOP MAMDC4 NETO1 ALK	2.09e-05	49	128	5	SM00192
Domain	LDLRA_2	HSPG2 SSPOP MAMDC4 NETO1 ALK	2.09e-05	49	128	5	PS50068
Domain	Cys_knot_C	SSPOP SLIT3 MUC2 MUC5AC	2.38e-05	25	128	4	IPR006207
Domain	CTCK_2	SSPOP SLIT3 MUC2 MUC5AC	2.38e-05	25	128	4	PS01225
Domain	Leu-rich_rpt_4	LRRK2 LRRIQ4 NLRC5	3.64e-05	10	128	3	IPR025875
Domain	LRR_4	LRRK2 LRRIQ4 NLRC5	3.64e-05	10	128	3	PF12799
Domain	C8	SSPOP MUC2 MUC5AC	6.61e-05	12	128	3	PF08742
Domain	TIL	SSPOP MUC2 MUC5AC	6.61e-05	12	128	3	PF01826
Domain	Unchr_dom_Cys-rich	SSPOP MUC2 MUC5AC	8.55e-05	13	128	3	IPR014853
Domain	C8	SSPOP MUC2 MUC5AC	8.55e-05	13	128	3	SM00832
Domain	VWFC_1	SSPOP THBS2 MUC2 MUC5AC	1.05e-04	36	128	4	PS01208
Domain	TIL_dom	SSPOP MUC2 MUC5AC	1.08e-04	14	128	3	IPR002919
Domain	VWFC_2	SSPOP THBS2 MUC2 MUC5AC	1.30e-04	38	128	4	PS50184
Domain	VWC	SSPOP THBS2 MUC2 MUC5AC	1.30e-04	38	128	4	SM00214
Domain	Transcrp_activ_Zfx/Zfy-dom	ZFX ZNF711	1.39e-04	3	128	2	IPR006794
Domain	Zfx_Zfy_act	ZFX ZNF711	1.39e-04	3	128	2	PF04704
Domain	LDLR_class-A_CS	HSPG2 SSPOP MAMDC4 NETO1	1.59e-04	40	128	4	IPR023415
Domain	VWF_type-D	SSPOP MUC2 MUC5AC	1.65e-04	16	128	3	IPR001846
Domain	VWFD	SSPOP MUC2 MUC5AC	1.65e-04	16	128	3	PS51233
Domain	VWD	SSPOP MUC2 MUC5AC	1.65e-04	16	128	3	SM00216
Domain	VWD	SSPOP MUC2 MUC5AC	1.65e-04	16	128	3	PF00094
Domain	VWF_dom	SSPOP THBS2 MUC2 MUC5AC	1.93e-04	42	128	4	IPR001007
Domain	Furin_repeat	PCSK5 ERBB2 EGFR	2.38e-04	18	128	3	IPR006212
Domain	FU	PCSK5 ERBB2 EGFR	2.38e-04	18	128	3	SM00261
Domain	Ldl_recept_a	HSPG2 SSPOP MAMDC4 NETO1	2.52e-04	45	128	4	PF00057
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB2 EGFR	2.77e-04	4	128	2	IPR016245
Domain	VWC_out	SSPOP MUC2 MUC5AC	2.81e-04	19	128	3	SM00215
Domain	EGF_CA	NID2 THBS2 THBS3 SCUBE1 MEGF8	3.12e-04	86	128	5	PF07645
Domain	L_dom-like	ERBB2 LRRK2 LRRIQ4 FBXL19 ADGRA2 NLRP9 EGFR SLIT3 NLRC5	4.36e-04	328	128	9	IPR032675
Domain	CT	SLIT3 MUC2 MUC5AC	4.40e-04	22	128	3	SM00041
Domain	Aminotrans_3	PHYKPL ETNPPL	4.60e-04	5	128	2	IPR005814
Domain	TSP_3	THBS2 THBS3	4.60e-04	5	128	2	PF02412
Domain	Aminotran_3	PHYKPL ETNPPL	4.60e-04	5	128	2	PF00202
Domain	TSP3	THBS2 THBS3	4.60e-04	5	128	2	PS51234
Domain	TSP_CTER	THBS2 THBS3	4.60e-04	5	128	2	PS51236
Domain	Thrombospondin_3_rpt	THBS2 THBS3	4.60e-04	5	128	2	IPR017897
Domain	TSP_type-3_rpt	THBS2 THBS3	4.60e-04	5	128	2	IPR028974
Domain	AA_TRANSFER_CLASS_3	PHYKPL ETNPPL	4.60e-04	5	128	2	PS00600
Domain	-	THBS2 THBS3	4.60e-04	5	128	2	4.10.1080.10
Domain	Thrombospondin_C	THBS2 THBS3	4.60e-04	5	128	2	IPR008859
Domain	TSP_C	THBS2 THBS3	4.60e-04	5	128	2	PF05735
Domain	Thrombospondin_3-like_rpt	THBS2 THBS3	4.60e-04	5	128	2	IPR003367
Domain	EGF_Ca-bd_CS	NID2 THBS3 SCUBE1 MEGF8 SLIT3	5.44e-04	97	128	5	IPR018097
Domain	EGF_CA	NID2 THBS3 SCUBE1 MEGF8 SLIT3	5.98e-04	99	128	5	PS01187
Domain	Laminin_G	HSPG2 THBS2 THBS3 SLIT3	6.71e-04	58	128	4	IPR001791
Domain	WxxW_domain	MUC2 MUC5AC	6.87e-04	6	128	2	IPR025155
Domain	Mucin2_WxxW	MUC2 MUC5AC	6.87e-04	6	128	2	PF13330
Domain	Recep_L_domain	ERBB2 EGFR	9.57e-04	7	128	2	PF01030
Domain	Furin-like	ERBB2 EGFR	9.57e-04	7	128	2	PF00757
Domain	Rcpt_L-dom	ERBB2 EGFR	9.57e-04	7	128	2	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB2 EGFR	9.57e-04	7	128	2	IPR006211
Domain	-	ERBB2 EGFR	9.57e-04	7	128	2	3.80.20.20
Domain	ZF_AN1	ZFAND2A ZFAND2B	1.27e-03	8	128	2	PS51039
Domain	ZnF_AN1	ZFAND2A ZFAND2B	1.27e-03	8	128	2	SM00154
Domain	-	ZFAND2A ZFAND2B	1.27e-03	8	128	2	4.10.1110.10
Domain	zf-AN1	ZFAND2A ZFAND2B	1.27e-03	8	128	2	PF01428
Domain	Znf_AN1	ZFAND2A ZFAND2B	1.27e-03	8	128	2	IPR000058
Domain	EGF	NID2 HSPG2 STAB1 THBS2 SLIT3	1.76e-03	126	128	5	PF00008
Domain	GFP-like	NID2 STAB1	2.46e-03	11	128	2	IPR023413
Domain	-	NID2 STAB1	2.46e-03	11	128	2	2.40.155.10
Domain	Leu-rich_rpt	LRRK2 LRRIQ4 FBXL19 ADGRA2 NLRP9 SLIT3 NLRC5	2.67e-03	271	128	7	IPR001611
Domain	MAD_homology1_Dwarfin-type	NFIB SMAD6	2.94e-03	12	128	2	IPR003619
Domain	DWA	NFIB SMAD6	2.94e-03	12	128	2	SM00523
Domain	MH1	NFIB SMAD6	2.94e-03	12	128	2	PF03165
Domain	ZF_RING_1	TRAF5 TRAIP MAP3K1 TRIM45 PJA2 ZNRF3 UNKL	3.95e-03	291	128	7	PS00518
Domain	Galactose-bd-like	PCSK5 LAMB2 SSPOP NTN4	3.99e-03	94	128	4	IPR008979
Domain	ConA-like_dom	HSPG2 MAMDC4 THBS2 THBS3 SLIT3 ALK	4.02e-03	219	128	6	IPR013320
Domain	LRR_1	LRRK2 LRRIQ4 FBXL19 ADGRA2 SLIT3 NLRC5	4.02e-03	219	128	6	PF00560
Domain	-	HSPG2 THBS2 THBS3 SLIT3	4.14e-03	95	128	4	2.60.120.200
Domain	ZF_RING_2	TRAF5 TRAIP MAP3K1 TRIM45 PJA2 ZNRF3 UNKL	4.49e-03	298	128	7	PS50089
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCSK5 HSPG2 ERBB2 HECTD4 LAMB2 KAT2A FBXL19 ADGRA2 LYST CASZ1 SCAP MEGF8 ZNRF3 PI4KA NLRC5 UNKL CAMSAP1 DOCK6 PRDM16 ZNF687	9.69e-09	1105	134	20	35748872
Pubmed	Targeted Therapy in Brain Metastases: Ready for Primetime?	ERBB2 EGFR ALK	2.23e-07	4	134	3	27249714
Pubmed	Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.	ERBB2 NF1 EGFR	2.23e-07	4	134	3	15652750
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	PCSK5 NID2 HSPG2 SFRP1 SPARC LAMB2 ADAM12 THBS2 SLIT3	5.54e-07	248	134	9	24006456
Pubmed	Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.	ERBB2 EGFR ALK	5.56e-07	5	134	3	22317764
Pubmed	The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin.	NID2 HSPG2 SPARC	1.11e-06	6	134	3	11956183
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERBB2 MAZ BRSK2 LYST RUSC2 CEP350 PJA2 NF1 MEGF8 PI4KA NHS MTREX CAMSAP1 DOCK6	6.43e-06	861	134	14	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ERBB2 HECTD4 WDR37 ADGRA2 STAB1 SLIT3 PLAGL2 KDM7A MTREX DOCK6 ZNF687	6.94e-06	529	134	11	14621295
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	ERBB2 MAP3K1 NF1 EGFR ALK	8.36e-06	71	134	5	28319113
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	HSPG2 XRN2 MAZ POT1 IKZF5 ZNF711 WDR75 EIF3C MTREX	9.04e-06	349	134	9	25665578
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	NID2 HSPG2 SPARC LAMB2 NTN4	1.41e-05	79	134	5	18757743
Pubmed	Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.	EGFR ALK	1.47e-05	2	134	2	24885886
Pubmed	Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.	ERBB2 EGFR	1.47e-05	2	134	2	25349977
Pubmed	A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.	ERBB2 ADAM12	1.47e-05	2	134	2	21986939
Pubmed	Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.	ERBB2 EGFR	1.47e-05	2	134	2	23871709
Pubmed	HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.	ERBB2 EGFR	1.47e-05	2	134	2	23594562
Pubmed	Identification of autophosphorylation sites of HER2/neu.	ERBB2 EGFR	1.47e-05	2	134	2	1706616
Pubmed	Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.	ERBB2 EGFR	1.47e-05	2	134	2	19946741
Pubmed	EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.	ERBB2 EGFR	1.47e-05	2	134	2	38416376
Pubmed	Evolutionary analysis of the ErbB receptor and ligand families.	ERBB2 EGFR	1.47e-05	2	134	2	10824084
Pubmed	Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients.	EGFR MUC5AC	1.47e-05	2	134	2	18285671
Pubmed	Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells.	ERBB2 EGFR	1.47e-05	2	134	2	25589492
Pubmed	Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.	ERBB2 EGFR	1.47e-05	2	134	2	15143334
Pubmed	Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.	EGFR ALK	1.47e-05	2	134	2	25577516
Pubmed	Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.	ERBB2 EGFR	1.47e-05	2	134	2	18199554
Pubmed	Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium.	ERBB2 EGFR	1.47e-05	2	134	2	17549377
Pubmed	The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.	ERBB2 EGFR	1.47e-05	2	134	2	27502168
Pubmed	Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.	ERBB2 EGFR	1.47e-05	2	134	2	23665199
Pubmed	Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.	HSPG2 MUC5AC	1.47e-05	2	134	2	23836919
Pubmed	Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation.	ERBB2 EGFR	1.47e-05	2	134	2	25217659
Pubmed	EGFR and HER2 expression in advanced biliary tract cancer.	ERBB2 EGFR	1.47e-05	2	134	2	19777609
Pubmed	Increased concentrations of growth factors and activation of the EGFR system in breast cancer.	ERBB2 EGFR	1.47e-05	2	134	2	23089711
Pubmed	EGFR Expression in HER2-Driven Breast Cancer Cells.	ERBB2 EGFR	1.47e-05	2	134	2	33260837
Pubmed	The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma.	ERBB2 EGFR	1.47e-05	2	134	2	34487971
Pubmed	Identification of a sequence in the matricellular protein SPARC that interacts with the scavenger receptor stabilin-1.	SPARC STAB1	1.47e-05	2	134	2	21308731
Pubmed	Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.	ERBB2 EGFR	1.47e-05	2	134	2	18946768
Pubmed	A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.	EGFR ALK	1.47e-05	2	134	2	11919185
Pubmed	Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors.	ERBB2 EGFR	1.47e-05	2	134	2	27273260
Pubmed	Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR.	ERBB2 EGFR	1.47e-05	2	134	2	12354693
Pubmed	Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice.	NF1 ALK	1.47e-05	2	134	2	28057529
Pubmed	Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.	EGFR ALK	1.47e-05	2	134	2	32221155
Pubmed	Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics.	ERBB2 EGFR	1.47e-05	2	134	2	25820115
Pubmed	[Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer].	EGFR ALK	1.47e-05	2	134	2	30201068
Pubmed	Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.	ERBB2 EGFR	1.47e-05	2	134	2	23220854
Pubmed	Dual mutations and complex mutations in metastatic nonsmall cell lung cancer: A single-institution experience from South India.	EGFR ALK	1.47e-05	2	134	2	29199696
Pubmed	CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.	EGFR ALK	1.47e-05	2	134	2	33862316
Pubmed	Gangliosides influence EGFR/ErbB2 heterodimer stability but they do not modify EGF-dependent ErbB2 phosphorylation.	ERBB2 EGFR	1.47e-05	2	134	2	20156584
Pubmed	EGFR and HER-2 oncogenes expression in an experimental model of two-stage chemically induced carcinogenesis in mouse skin.	ERBB2 EGFR	1.47e-05	2	134	2	38443188
Pubmed	Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer.	ERBB2 EGFR	1.47e-05	2	134	2	17611648
Pubmed	Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues.	THBS2 THBS3	1.47e-05	2	134	2	10329465
Pubmed	Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.	CTBP1 SMAD6	1.47e-05	2	134	2	14645520
Pubmed	A novel dual EGFR/HER2 inhibitor KU004 induces cell cycle arrest and apoptosis in HER2-overexpressing cancer cells.	ERBB2 EGFR	1.47e-05	2	134	2	26437915
Pubmed	Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC.	SPARC STAB1	1.47e-05	2	134	2	16670288
Pubmed	EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection.	ERBB2 EGFR	1.47e-05	2	134	2	22891338
Pubmed	Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors.	ERBB2 EGFR	1.47e-05	2	134	2	20962551
Pubmed	Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2.	ERBB2 EGFR	1.47e-05	2	134	2	29329808
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins.	MUC2 MUC5AC	1.47e-05	2	134	2	23832517
Pubmed	Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.	MUC2 MUC5AC	1.47e-05	2	134	2	23832516
Pubmed	Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.	EGFR ALK	1.47e-05	2	134	2	22569898
Pubmed	Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with 177Lu Is More Potent for Killing Human Breast Cancer Cells That Coexpress HER2 and EGFR Than Single-Receptor-Targeted (SRT) Radiation Nanomedicines.	ERBB2 EGFR	1.47e-05	2	134	2	32022567
Pubmed	Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA).	ERBB2 EGFR	1.47e-05	2	134	2	21480528
Pubmed	Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.	ERBB2 EGFR	1.47e-05	2	134	2	21087480
Pubmed	Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.	EGFR ALK	1.47e-05	2	134	2	26555338
Pubmed	A Comparison of Immunohistochemical Expression of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 in Dental Follicles with Different Radiographic Sizes.	ERBB2 EGFR	1.47e-05	2	134	2	39205824
Pubmed	Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells.	ERBB2 EGFR	1.47e-05	2	134	2	19287975
Pubmed	The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR.	ERBB2 EGFR	1.47e-05	2	134	2	21911055
Pubmed	Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancer.	EGFR ALK	1.47e-05	2	134	2	29582563
Pubmed	Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.	EGFR ALK	1.47e-05	2	134	2	28557060
Pubmed	Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.	ERBB2 EGFR	1.47e-05	2	134	2	12586780
Pubmed	Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.	ERBB2 EGFR	1.47e-05	2	134	2	30296252
Pubmed	EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.	ERBB2 EGFR	1.47e-05	2	134	2	30610926
Pubmed	Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.	MUC2 MUC5AC	1.47e-05	2	134	2	17203232
Pubmed	EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells.	ERBB2 EGFR	1.47e-05	2	134	2	25935365
Pubmed	[Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].	EGFR ALK	1.47e-05	2	134	2	33879893
Pubmed	Serum levels of epidermal growth factor and HER-2 neu in non small-cell lung cancer: prognostic correlation.	ERBB2 EGFR	1.47e-05	2	134	2	19093231
Pubmed	Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.	ERBB2 EGFR	1.47e-05	2	134	2	32917240
Pubmed	EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy.	ERBB2 EGFR	1.47e-05	2	134	2	18650488
Pubmed	Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.	ERBB2 EGFR	1.47e-05	2	134	2	18182111
Pubmed	Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.	ERBB2 EGFR	1.47e-05	2	134	2	17626639
Pubmed	Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice.	ERBB2 EGFR	1.47e-05	2	134	2	26330166
Pubmed	Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.	EGFR ALK	1.47e-05	2	134	2	26537995
Pubmed	The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation.	ERBB2 EGFR	1.47e-05	2	134	2	26114632
Pubmed	TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.	TRAF5 CD40	1.47e-05	2	134	2	19805155
Pubmed	NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA.	ERBB2 NFIB	1.47e-05	2	134	2	33576439
Pubmed	Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan.	ERBB2 EGFR	1.47e-05	2	134	2	38040921
Pubmed	HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.	ERBB2 EGFR	1.47e-05	2	134	2	28388586
Pubmed	ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.	ADAM12 EGFR	1.47e-05	2	134	2	36512304
Pubmed	EGFR and erbB2 mutation status in Japanese lung cancer patients.	ERBB2 EGFR	1.47e-05	2	134	2	16003726
Pubmed	Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.	EGFR ALK	1.47e-05	2	134	2	23154552
Pubmed	Asp746 to glycine change may have a greater influence than Cys751 to serine change in accounting for ligand selectivity between EGFR and HER-2 at the ATP site.	ERBB2 EGFR	1.47e-05	2	134	2	16184431
Pubmed	Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.	EGFR ALK	1.47e-05	2	134	2	27776643
Pubmed	Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel.	ERBB2 EGFR	1.47e-05	2	134	2	23213241
Pubmed	Ganglioside GM(3) is stably associated to tyrosine-phosphorylated ErbB2/EGFR receptor complexes and EGFR monomers, but not to ErbB2.	ERBB2 EGFR	1.47e-05	2	134	2	17521961
Pubmed	Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.	ERBB2 EGFR	1.47e-05	2	134	2	12683217
Pubmed	Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.	ERBB2 EGFR	1.47e-05	2	134	2	15572377
Pubmed	EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.	ERBB2 EGFR	1.47e-05	2	134	2	24792576
Pubmed	ErbB1 and ErbB2 overexpression in patients with sinonasal inverted papilloma and inverted papilloma with squamous cell carcinoma in China.	ERBB2 EGFR	1.47e-05	2	134	2	31556771
Pubmed	Characterization of EGFR and ErbB2 expression in atopic dermatitis patients.	ERBB2 EGFR	1.47e-05	2	134	2	22552355
Pubmed	Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line.	ERBB2 EGFR	1.47e-05	2	134	2	22200885
Pubmed	Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer.	ERBB2 EGFR	1.47e-05	2	134	2	15447984
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF131 ZNF142 ZFAT ZNF366 MAZ TRPS1 ZNF57 ZNF317 ZNF251 ZNF414 CASZ1 ZNF169 ZFX IKZF5 ZNF711 BCL6B FIZ1 PLAGL1 PLAGL2 ZNF350 PRDM16	1.43e-11	718	86	21	28
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB2 EGFR	1.33e-04	4	86	2	1096
GeneFamily	Zinc fingers AN1-type\|UPF1 like RNA helicases	ZFAND2A ZFAND2B	6.15e-04	8	86	2	63
Coexpression	NABA_ECM_GLYCOPROTEINS	NID2 SPARC LAMB2 SSPOP NTN4 THBS2 THBS3 OTOGL SLIT3	6.00e-07	191	133	9	MM17059
Coexpression	NABA_MATRISOME	PCSK5 NID2 HSPG2 SFRP1 SPARC MMP23B LAMB2 ADAM12 SSPOP NTN4 THBS2 THBS3 SCUBE1 MEGF8 OTOGL SLIT3 MUC2 MUC5AC MEGF10	8.39e-07	1008	133	19	MM17056
Coexpression	NABA_CORE_MATRISOME	NID2 HSPG2 SPARC LAMB2 SSPOP NTN4 THBS2 THBS3 OTOGL SLIT3	1.26e-06	270	133	10	MM17057
Coexpression	FARMER_BREAST_CANCER_CLUSTER_4	NID2 SPARC ADAM12 THBS2	2.31e-06	19	133	4	M15125
Coexpression	NABA_MATRISOME	PCSK5 NID2 HSPG2 SFRP1 SPARC MMP23B LAMB2 ADAM12 SSPOP NTN4 THBS2 THBS3 SCUBE1 MEGF8 SLIT3 MUC2 MUC5AC MEGF10	4.57e-06	1026	133	18	M5889
Coexpression	TCGA_GLIOBLASTOMA_MUTATED	ERBB2 NF1 EGFR	7.02e-06	8	133	3	M19387
Coexpression	NABA_ECM_GLYCOPROTEINS	NID2 SPARC LAMB2 SSPOP NTN4 THBS2 THBS3 SLIT3	7.48e-06	196	133	8	M3008
Coexpression	NABA_CORE_MATRISOME	NID2 HSPG2 SPARC LAMB2 SSPOP NTN4 THBS2 THBS3 SLIT3	1.18e-05	275	133	9	M5884
Coexpression	NABA_BASEMENT_MEMBRANES	NID2 HSPG2 LAMB2 NTN4	5.03e-05	40	133	4	M5887
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN	HECTD4 ZNF169 MAP3K1 THBS2 GLG1 MARF1 PRDM16	7.49e-05	200	133	7	M9935
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_500	PRSS35 NID2 TRAF5 SFRP1 GRIN2C ADAM12 PLAGL1	1.27e-05	129	127	7	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k2
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	BOC SFRP1 TRPS1 ZNF711 SCUBE1 EGFR NFIB PLAGL1 MANSC4	3.15e-05	265	127	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 HSPG2 SFRP1 SPARC MMP23B LAMB2 THBS3 RAB34 EGFR NFIB SLIT3	8.30e-13	195	134	12	69a29d03e664b72f32d41876510c62345c3aed31
ToppCell	facs-GAT-Fat-3m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 HSPG2 SFRP1 SPARC MMP23B LAMB2 THBS3 RAB34 EGFR NFIB SLIT3	8.30e-13	195	134	12	1cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 HSPG2 SFRP1 SPARC MMP23B LAMB2 THBS3 RAB34 EGFR NFIB SLIT3	8.30e-13	195	134	12	9cef6f18664518060af7c192310dddce6d70345a
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 THBS3 NFIB SLIT3 PLAGL1	3.29e-10	190	134	10	947807863a9b247c301c6cf63d6fd5a2c8018e66
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 THBS3 NFIB SLIT3 PLAGL1	3.47e-10	191	134	10	db4943dd19207663fb9e27f8940fa4b06a933625
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC NID2 HSPG2 MMP23B LAMB2 XDH THBS3 EGFR GLG1 SLIT3	4.46e-10	196	134	10	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC NID2 HSPG2 MMP23B LAMB2 XDH THBS3 EGFR GLG1 SLIT3	4.46e-10	196	134	10	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC NID2 SFRP1 SPARC MMP23B ADAM12 THBS2 NFIB PLAGL1	4.69e-10	197	134	10	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 THBS3 NFIB PLAGL1	8.96e-09	197	134	9	6b6440f1baad5680cf9e13ca3ab72a2c65523d59
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC NID2 SFRP1 SPARC ADAM12 RAB34 NFIB PLAGL1	9.37e-09	198	134	9	d9ffc6589ed510ffa60c591f2a0fe123210f1455
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC NID2 SFRP1 SPARC ADAM12 THBS3 NFIB PLAGL1	9.79e-09	199	134	9	bfc157be6e9f84739848eb19b718de5b17f3fa88
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PRSS35 BOC SFRP1 SPARC THBS2 NFIB SLIT3 PLAGL1	9.41e-08	185	134	8	c85bba1210f1d389add3e40be9b96abac40cf8c1
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 NFIB PLAGL1	9.80e-08	186	134	8	c0a036096c2cb23305605b8aaf18869d6e0fb512
ToppCell	Fibroblast-C\|World / shred on cell class and cell subclass (v4)	PRSS35 SFRP1 SPARC MMP23B THBS2 RAB34 NFIB SLIT3	1.11e-07	189	134	8	58e0400fbab5a0755504275aef5cf7986149abab
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 EGFR PLAGL1	1.20e-07	191	134	8	4b50fdd310701251e64e16cd2d07ce03dbfd3e3e
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 EGFR PLAGL1	1.20e-07	191	134	8	75d2197076a9dfc868e8baf95bd4c5e44f438e3e
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 SFRP1 SPARC MMP23B THBS2 NFIB SLIT3 PLAGL1	1.25e-07	192	134	8	ad48c941a3ddfd9a5146bafc2209da577bb50531
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 SFRP1 SPARC MMP23B THBS2 RAB34 NFIB PLAGL1	1.25e-07	192	134	8	19b94f254d51b9bda3d9b7c6f85e27ecb58409c8
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SPARC MMP23B LAMB2 THBS3 NFIB SLIT3	1.30e-07	193	134	8	f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SPARC MMP23B LAMB2 THBS3 NFIB SLIT3	1.30e-07	193	134	8	85faf6c5ce4769615a4eca036e2ba307e176bb52
ToppCell	facs-MAT-Fat-3m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SPARC MMP23B LAMB2 THBS3 NFIB SLIT3	1.30e-07	193	134	8	110a7d2ba7d066c2be38be98b643b76c520dd980
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SFRP1 MMP23B THBS3 RAB34 NFIB SLIT3	1.35e-07	194	134	8	da926441053b499cb5107ccb116fb1b3844d82b7
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SFRP1 MMP23B THBS3 RAB34 NFIB SLIT3	1.35e-07	194	134	8	54a7f693966b5c02f6b248950ddb5fa32af3ae67
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SFRP1 MMP23B THBS3 RAB34 NFIB SLIT3	1.35e-07	194	134	8	f34b3bbdebf56f66ff499e390e5515a4a4093f90
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SPARC MMP23B ADAM12 THBS2 NFIB SLIT3	1.52e-07	197	134	8	6668f0da54f3bf96769275e668cd57e00b8a5ef9
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SPARC MMP23B ADAM12 THBS2 NFIB SLIT3	1.52e-07	197	134	8	7c275a2ac24a9a4f83fceda93a067e754837102f
ToppCell	tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	BOC SFRP1 SPARC MMP23B ADGRA2 THBS2 NFIB SLIT3	1.58e-07	198	134	8	74f2c7ef702b25a5b99e56121229e678ed992524
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SFRP1 SPARC MMP23B THBS2 NFIB PLAGL1	1.65e-07	199	134	8	103f657132e830a0e5efeb745afb4b77c208a1fa
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SFRP1 SPARC ADAM12 RAB34 NFIB PLAGL1	1.65e-07	199	134	8	c007cd51577e31553395ceaed70ad447e5854546
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SFRP1 SPARC THBS2 THBS3 NFIB PLAGL1	1.65e-07	199	134	8	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	BOC SFRP1 SPARC LAMB2 THBS2 EGFR NFIB SLIT3	1.65e-07	199	134	8	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC NID2 SFRP1 SPARC MMP23B THBS2 NFIB	1.65e-07	199	134	8	83383d9ae4f501754fd3da0215ce6f0e3c70562c
ToppCell	(5)_Fibroblast-D\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	BOC NID2 SFRP1 SPARC ADGRA2 THBS2 NFIB SLIT3	1.65e-07	199	134	8	3f415620ad8b8d8c6871e1353e13f87b281fcc0e
ToppCell	15-Airway-Mesenchymal\|Airway / Age, Tissue, Lineage and Cell class	PRSS35 BOC SPARC MMP23B THBS2 RAB34 NFIB SLIT3	1.71e-07	200	134	8	13c4835b98e1bb91c2d04e08cdeaed8eba30b1d9
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ADAM12 SSPOP KCNH6 SCUBE1 NLRC5 NHS	4.38e-07	154	134	7	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4\|TCGA-Lung / Sample_Type by Project: Shred V9	NID2 SPARC ADAM12 ADGRA2 STAB1 THBS2 RNASE2	7.87e-07	168	134	7	aefea14b8b1c1b6a05f827effd22ba15274fddc9
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 SFRP1 MMP23B MAMDC4 THBS3 RAB34 KCND1	1.45e-06	184	134	7	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC SFRP1 SPARC ADAM12 NFIB SLIT3	1.45e-06	184	134	7	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	Frontal_cortex-Endothelial\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NID2 HSPG2 SPARC LAMB2 ADGRA2 DOCK6 SMAD6	1.67e-06	188	134	7	a43392dbd10fc7dbfb31be39b8af8a7ea121c894
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRSS35 BOC PCSK5 SFRP1 THBS2 RAB34 MEGF10	1.73e-06	189	134	7	cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRSS35 BOC PCSK5 SFRP1 THBS2 RAB34 MEGF10	1.73e-06	189	134	7	102501eee7760d5882dec41ea9d00147b3f4fb73
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC HSPG2 SPARC MMP23B THBS3 EGFR SLIT3	1.73e-06	189	134	7	f0a2d4ef9896d764971ebbc6952510c128bb76e8
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC HSPG2 SPARC MMP23B THBS3 EGFR SLIT3	1.73e-06	189	134	7	378f26f751ab4b470948c35dd8347de72dd12ff7
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRSS35 BOC PCSK5 SFRP1 THBS2 RAB34 MEGF10	1.73e-06	189	134	7	6e83bf855d4771885b60bb8992df2f9b508eef97
ToppCell	facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SFRP1 SPARC MMP23B LAMB2 EGFR SLIT3	1.79e-06	190	134	7	dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd
ToppCell	facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SFRP1 SPARC MMP23B LAMB2 EGFR SLIT3	1.79e-06	190	134	7	0bb06df3d5a50416854370f234718c6cec3d773b
ToppCell	facs-SCAT-Fat-24m-Mesenchymal\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SFRP1 SPARC MMP23B LAMB2 EGFR SLIT3	1.79e-06	190	134	7	008290bb5c79446681dd6bf354336c57ad0d6f13
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SFRP1 SPARC MMP23B THBS3 RAB34 NFIB	1.79e-06	190	134	7	97772e69e6f51ebffbb5433ca7b40f1048723220
ToppCell	droplet-Lung-nan-18m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC SFRP1 SPARC MMP23B THBS3 RAB34 NFIB	1.79e-06	190	134	7	72c2b824acdc43139e6635785df3ed3feb58ec46
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 SFRP1 MMP23B THBS2 THBS3 EGFR SLIT3	1.85e-06	191	134	7	2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PRSS35 SFRP1 SPARC THBS2 NFIB SLIT3 PLAGL1	1.85e-06	191	134	7	053b3664f509baa107feaf90730f80ebf9ac8f14
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP1 SPARC MMP23B THBS2 THBS3 NFIB SLIT3	1.85e-06	191	134	7	9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC HSPG2 MMP23B THBS3 RAB34 EGFR SLIT3	1.92e-06	192	134	7	c3707243c5590d852c9f28429c96f50a1fa6b0dc
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPARC MMP23B LAMB2 THBS2 THBS3 NFIB SLIT3	1.92e-06	192	134	7	fc940f91ff8e051631dbf25e6e8d73cf8337eccb
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPARC MMP23B LAMB2 THBS2 THBS3 NFIB SLIT3	1.92e-06	192	134	7	7a2e79490e4f7058bb76b46c45b5df9f729e3146
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC HSPG2 MMP23B THBS3 RAB34 EGFR SLIT3	1.92e-06	192	134	7	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	droplet-Fat-Mat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SFRP1 MMP23B RAB34 NFIB SLIT3	1.99e-06	193	134	7	ebd090d7801480b3cee45caac3d30cc991836769
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SFRP1 MMP23B RAB34 NFIB SLIT3	1.99e-06	193	134	7	22c58032e58730715224d7934968ce92d150b0e8
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 SPARC MMP23B LAMB2 THBS3 RAB34 SLIT3	1.99e-06	193	134	7	858a186804b36d45957238d3d3eed2768b961641
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 SPARC MMP23B LAMB2 THBS3 RAB34 SLIT3	1.99e-06	193	134	7	7865e7ec0a288249540d4cba94ae01c93e1b617c
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC SPARC MMP23B LAMB2 THBS3 NFIB SLIT3	1.99e-06	193	134	7	25248b8e65d558b1a96a87c93e3e5b4c0ba168fe
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC SPARC MMP23B LAMB2 THBS3 NFIB SLIT3	1.99e-06	193	134	7	f1f1097204e07a7bed416425b8256942038a734f
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP1 SPARC MMP23B THBS2 THBS3 NFIB SLIT3	1.99e-06	193	134	7	051f61156b0e2e95292b2d8377faf3190b50f264
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SFRP1 MMP23B RAB34 NFIB SLIT3	1.99e-06	193	134	7	573ad2f848bede1fe20c7b4b352a9242ec294725
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC HSPG2 SFRP1 MMP23B THBS3 RAB34 EGFR	2.06e-06	194	134	7	5594f7437448cb4b37d2d100f44d30c4a367df26
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|World / Lineage and Cell class	BOC HSPG2 SPARC LAMB2 THBS2 THBS3 NFIB	2.06e-06	194	134	7	c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BOC NID2 SPARC MMP23B ADAM12 THBS2 SLIT3	2.06e-06	194	134	7	02b8102be9414d6964cd71019613edff6d88b893
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BOC SFRP1 SPARC TRPS1 MMP23B NFIB SLIT3	2.06e-06	194	134	7	85e00861c5068a27d0cf0ae677f420c8245baa9a
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC SFRP1 SPARC LAMB2 THBS2 THBS3 NFIB	2.06e-06	194	134	7	889c6e231bdd5b59902c7d2afdc077360b1d3256
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BOC NID2 SFRP1 ADAM12 THBS2 SLIT3 NHS	2.13e-06	195	134	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC HSPG2 LAMB2 THBS3 EGFR GLG1 MTREX	2.13e-06	195	134	7	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRSS35 BOC SFRP1 SPARC MMP23B ADGRA2 THBS2	2.20e-06	196	134	7	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	ASK454-Endothelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SPARC LAMB2 CASZ1 BCL6B NFIB DOCK6 SMAD6	2.20e-06	196	134	7	14dd6956ef420b660be0baf52a66960e57d75d16
ToppCell	ASK454-Endothelial-Endothelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SPARC LAMB2 CASZ1 BCL6B NFIB DOCK6 SMAD6	2.20e-06	196	134	7	2b777a2026b56839112fd179f2db482c49f4594a
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	PRSS35 BOC NID2 SPARC MMP23B ADGRA2 THBS2	2.20e-06	196	134	7	54aefcebf13704f51de84379e2e22ec0734b9461
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	BOC SFRP1 SPARC LAMB2 THBS2 PRDM16 MEGF10	2.28e-06	197	134	7	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SPARC LAMB2 ADAM12 THBS2 SLIT3 SPOCD1 MEGF10	2.28e-06	197	134	7	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BOC NID2 HSPG2 THBS2 EGFR NFIB SLIT3	2.28e-06	197	134	7	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	BOC SFRP1 SPARC LAMB2 THBS2 PRDM16 MEGF10	2.28e-06	197	134	7	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BOC NID2 HSPG2 THBS2 EGFR NFIB SLIT3	2.28e-06	197	134	7	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BOC NID2 HSPG2 THBS2 EGFR NFIB SLIT3	2.28e-06	197	134	7	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 SPARC LAMB2 THBS2 THBS3 NFIB SLIT3	2.35e-06	198	134	7	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC NID2 SPARC MMP23B THBS2 NFIB	2.35e-06	198	134	7	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 HSPG2 SPARC THBS3 EGFR GLG1 SLIT3	2.35e-06	198	134	7	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PCSK5 NID2 HSPG2 SPARC THBS2 EGFR NFIB	2.35e-06	198	134	7	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	Non-neuronal-Dividing-Radial_Glia-vRG-20\|World / Primary Cells by Cluster	BOC SFRP1 SPARC THBS2 EGFR PRDM16 MEGF10	2.35e-06	198	134	7	bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 HSPG2 SPARC MMP23B THBS3 RAB34 PLAGL1	2.35e-06	198	134	7	b086af292a508a156266c2d899ba1caf820bf61c
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 BOC ZFAND2A SFRP1 SPARC THBS2 NFIB	2.35e-06	198	134	7	cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 HSPG2 SPARC MMP23B THBS3 RAB34 PLAGL1	2.35e-06	198	134	7	1b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC PCSK5 SPARC MMP23B THBS2 THBS3 RAB34	2.35e-06	198	134	7	524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 SPARC LAMB2 THBS2 EGFR NFIB PLAGL1	2.43e-06	199	134	7	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SPARC MMP23B NTN4 EGFR NFIB PLAGL1 MEGF10	2.43e-06	199	134	7	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	368C-Fibroblasts-Fibroblast-D-\|368C / Donor, Lineage, Cell class and subclass (all cells)	BOC SFRP1 SPARC MMP23B THBS2 NFIB SLIT3	2.43e-06	199	134	7	5a425e7d11c5911ff5855c27a7f058a7ed7abbb0
ToppCell	Non-neuronal-Postmitotic-Endothelial\|World / Primary Cells by Cluster	NID2 HSPG2 SPARC ADAM12 ADGRA2 BCL6B DOCK6	2.43e-06	199	134	7	b9763ac9857a60db6f1f104fe1e9ea2266cf931b
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial-24\|World / Primary Cells by Cluster	NID2 HSPG2 SPARC ADAM12 ADGRA2 BCL6B DOCK6	2.43e-06	199	134	7	0b4edf3e359749827ef978a77b5267ddde732d71
ToppCell	368C-Fibroblasts-Fibroblast-D\|368C / Donor, Lineage, Cell class and subclass (all cells)	BOC SFRP1 SPARC MMP23B THBS2 NFIB SLIT3	2.43e-06	199	134	7	66545eb7f65e450b742628fd431956e13330a0d3
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial\|World / Primary Cells by Cluster	NID2 HSPG2 SPARC ADAM12 ADGRA2 BCL6B DOCK6	2.43e-06	199	134	7	9e01eee126247a0696c71b019f855a8a41a0ede3
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC SFRP1 LAMB2 THBS2 THBS3 EGFR PLAGL1	2.43e-06	199	134	7	95d95e9b7bd3933188998ae94986213eb0f1e5ea
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SPARC MMP23B NTN4 EGFR NFIB PLAGL1 MEGF10	2.43e-06	199	134	7	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PRSS35 SFRP1 SPARC MMP23B THBS2 THBS3 PLAGL1	2.43e-06	199	134	7	ab0589c068c24aa989bdca083504fbad0c15221d
Drug	Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A	HSPG2 MAZ ADAM12 ZFX NF1 NFIB CD40 ZNF350 CAMSAP1 ALK	2.18e-07	194	133	10	4139_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	CCDC170 SFRP1 ERCC4 PHTF2 IKZF5 THBS3 NF1 UNKL ALK	2.34e-06	196	133	9	4000_UP
Disease	Malignant neoplasm of breast	BOC NID2 ERBB2 SFRP1 ZNF366 XDH ADAM12 MAMDC4 MAP3K1 THBS3 NLRP9 NF1 EGFR OTOGL CD40 NLRC5 NHS SPOCD1 ALK	1.56e-07	1074	126	19	C0006142
Disease	cystitis (is_marker_for)	MUC2 MUC5AC	1.81e-05	2	126	2	DOID:1679 (is_marker_for)
Disease	Glioma	ERBB2 POT1 NF1 EGFR ALK	3.66e-05	87	126	5	C0017638
Disease	sputum mucin-5B amount	MUC2 MUC5AC	5.41e-05	3	126	2	OBA_2050332
Disease	Adrenocortical carcinoma	SPARC EGFR ZNRF3	5.92e-05	18	126	3	C0206686
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 XDH EGFR	7.01e-05	19	126	3	DOID:2876 (is_marker_for)
Disease	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	ERCC4 TRAIP	1.08e-04	4	126	2	C3808988
Disease	arecaidine measurement	PYROXD2 SLIT3	1.79e-04	5	126	2	EFO_0801112
Disease	mucinous adenocarcinoma (is_marker_for)	MUC2 MUC5AC	1.79e-04	5	126	2	DOID:3030 (is_marker_for)
Disease	Cetuximab response	ERBB2 EGFR	1.79e-04	5	126	2	cv:CN077967
Disease	Panitumumab response	ERBB2 EGFR	1.79e-04	5	126	2	cv:CN077999
Disease	cardiomyopathy (implicated_via_orthology)	ERBB2 SPARC XDH EGFR	2.47e-04	71	126	4	DOID:0050700 (implicated_via_orthology)
Disease	Thrombocytopenia	SPARC XDH IKZF5	2.56e-04	29	126	3	C0040034
Disease	calcinosis (is_marker_for)	ERBB2 SPARC	2.68e-04	6	126	2	DOID:182 (is_marker_for)
Disease	ovarian neoplasm	ERBB2 SPARC ERCC4 EGFR ALOX12B	2.82e-04	134	126	5	C0919267
Disease	Malignant neoplasm of ovary	ERBB2 SPARC ERCC4 EGFR ALOX12B	3.12e-04	137	126	5	C1140680
Disease	Rectal Neoplasms	EGFR MUC2	3.75e-04	7	126	2	C0034885
Disease	Rectal Carcinoma	EGFR MUC2	3.75e-04	7	126	2	C0007113
Disease	asymmetrical dimethylarginine measurement	ZFAT PYROXD2	4.98e-04	8	126	2	EFO_0006522
Disease	Neoplasm Recurrence, Local	ERBB2 EGFR ALK	6.21e-04	39	126	3	C0027643
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	MUC2 MUC5AC	6.39e-04	9	126	2	EFO_0009824
Disease	PITUITARY DWARFISM I	ERCC4 TRAIP	6.39e-04	9	126	2	C0342573
Disease	multiple system atrophy	PYROXD2 XDH USP48	6.69e-04	40	126	3	EFO_1001050
Disease	Cutaneous Melanoma	ERCC4 NF1 ALK	7.20e-04	41	126	3	C0151779
Disease	high grade glioma (is_implicated_in)	ERBB2 POT1 NF1	7.73e-04	42	126	3	DOID:3070 (is_implicated_in)
Disease	FEV/FEC ratio	BOC PCSK5 NID2 HSPG2 SFRP1 TRPS1 ADAM12 MAP3K1 NTN4 THBS3 NETO1 KDM7A PRDM16 SMAD6	7.80e-04	1228	126	14	EFO_0004713
Disease	Head and Neck Carcinoma	ERBB2 EGFR	7.96e-04	10	126	2	C3887461
Disease	gallbladder neoplasm	ERBB2 EGFR	9.70e-04	11	126	2	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB2 EGFR	9.70e-04	11	126	2	C0153452
Disease	Papilloma	ERBB2 EGFR	1.16e-03	12	126	2	C0030354
Disease	Papillomatosis	ERBB2 EGFR	1.16e-03	12	126	2	C0205875
Disease	Papilloma, Squamous Cell	ERBB2 EGFR	1.16e-03	12	126	2	C0205874
Disease	colitis (implicated_via_orthology)	CD40 MUC2	1.37e-03	13	126	2	DOID:0060180 (implicated_via_orthology)
Disease	Carcinoma, Granular Cell	ERBB2 EGFR MUC2 ALOX12B	1.57e-03	116	126	4	C0205644
Disease	Adenocarcinoma, Tubular	ERBB2 EGFR MUC2 ALOX12B	1.57e-03	116	126	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	ERBB2 EGFR MUC2 ALOX12B	1.57e-03	116	126	4	C0205642
Disease	Carcinoma, Cribriform	ERBB2 EGFR MUC2 ALOX12B	1.57e-03	116	126	4	C0205643
Disease	Adenocarcinoma, Basal Cell	ERBB2 EGFR MUC2 ALOX12B	1.57e-03	116	126	4	C0205641
Disease	Adenocarcinoma	ERBB2 EGFR MUC2 ALOX12B	1.57e-03	116	126	4	C0001418
Disease	Neoplasm of lung	ERBB2 EGFR	1.59e-03	14	126	2	cv:C0024121
Disease	median neuropathy (biomarker_via_orthology)	ERBB2 EGFR	1.59e-03	14	126	2	DOID:571 (biomarker_via_orthology)
Disease	Lung cancer	ERBB2 EGFR	1.59e-03	14	126	2	cv:C0242379
Disease	LUNG CANCER	ERBB2 EGFR	1.59e-03	14	126	2	211980
Disease	phospholipids in medium HDL measurement	TRPS1 NLRC5 DOCK6	1.70e-03	55	126	3	EFO_0022295
Disease	polyp of colon	BOC NID2 NTN4	1.79e-03	56	126	3	MONDO_0021400
Disease	caffeine measurement	LRRK2 LAMB2	1.83e-03	15	126	2	EFO_0021177
Disease	total lipids in medium HDL measurement	TRPS1 NLRC5 DOCK6	1.98e-03	58	126	3	EFO_0022310
Disease	free cholesterol in medium HDL measurement	TRPS1 NLRC5 DOCK6	1.98e-03	58	126	3	EFO_0022267
Disease	cholesterol in medium HDL measurement	TRPS1 NLRC5 DOCK6	2.08e-03	59	126	3	EFO_0021903
Disease	asthma (biomarker_via_orthology)	EGFR CD40 MUC5AC	2.08e-03	59	126	3	DOID:2841 (biomarker_via_orthology)
Disease	neuroimaging measurement	SFRP1 TRPS1 BRSK2 METTL4 MAP3K1 EFTUD2 NF1 WDR75 EGFR ZNRF3 NFIB PRDM16	2.12e-03	1069	126	12	EFO_0004346
Disease	Sarcomatoid Renal Cell Carcinoma	ERBB2 LRRK2 ALK ALOX12B	2.25e-03	128	126	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	ERBB2 LRRK2 ALK ALOX12B	2.25e-03	128	126	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	ERBB2 LRRK2 ALK ALOX12B	2.25e-03	128	126	4	C1266044
Disease	Papillary Renal Cell Carcinoma	ERBB2 LRRK2 ALK ALOX12B	2.25e-03	128	126	4	C1306837
Disease	Renal Cell Carcinoma	ERBB2 LRRK2 ALK ALOX12B	2.25e-03	128	126	4	C0007134
Disease	renal cell carcinoma (is_marker_for)	ERBB2 SFRP1 SPARC EGFR	2.25e-03	128	126	4	DOID:4450 (is_marker_for)
Disease	free cholesterol in HDL measurement	TRPS1 NLRC5 DOCK6	2.28e-03	61	126	3	EFO_0022264
Disease	phospholipids in HDL measurement	TRPS1 NLRC5 DOCK6	2.28e-03	61	126	3	EFO_0022293
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	CD40 MUC2	2.36e-03	17	126	2	DOID:8677 (biomarker_via_orthology)
Disease	oral squamous cell carcinoma (is_marker_for)	ERBB2 EGFR DOCK6	2.50e-03	63	126	3	DOID:0050866 (is_marker_for)
Disease	total lipids in HDL measurement	TRPS1 NLRC5 DOCK6	2.50e-03	63	126	3	EFO_0022307
Disease	Global developmental delay	ZNF142 BRSK2 WDR37 NFIB	2.58e-03	133	126	4	C0557874
Disease	brain infarction	THBS2 ALK	2.65e-03	18	126	2	EFO_0004277
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 TRPS1	2.95e-03	19	126	2	DOID:2256 (is_implicated_in)
Disease	Parkinson's disease (is_marker_for)	ERBB2 LRRK2 EGFR	2.98e-03	67	126	3	DOID:14330 (is_marker_for)
Disease	Animal Mammary Neoplasms	ERBB2 TRPS1 XDH EGFR	3.27e-03	142	126	4	C0024667
Disease	Mammary Carcinoma, Animal	ERBB2 TRPS1 XDH EGFR	3.27e-03	142	126	4	C1257925
Disease	Malignant Glioma	ERBB2 POT1 NF1	3.38e-03	70	126	3	C0555198
Disease	mixed gliomas	ERBB2 POT1 NF1	3.38e-03	70	126	3	C0259783
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ERBB2 LRRK2 ALK ALOX12B	3.79e-03	148	126	4	C0279702
Disease	total lipids in large HDL	TRPS1 CD40 DOCK6	3.95e-03	74	126	3	EFO_0022189
Disease	Colonic Neoplasms	ERBB2 SPARC EGFR ALOX12B	4.17e-03	152	126	4	C0009375

Protein segments in the cluster

Peptide	Gene	Start	Entry
NHTTCQHCHRQFPTP	ZNF280B	341	Q86YH2
QANCPPGHHHCQNKV	MAMDC4	226	Q6UXC1
GPKHSDCLACLHFNH	ERBB2	246	P04626
LHFNHSGICELHCPA	ERBB2	256	P04626
LHNHQPCGCLVFSHP	ADGRF3	201	Q8IZF5
DCVTLHCGLNEHNHH	CTBP1	231	Q13363
QLCCEGALELHTHHL	ADGRA2	236	Q96PE1
LHKAHFHCVVEECGA	CASZ1	1026	Q86V15
FCHIHNCIHRDIKPE	CDKL4	116	Q5MAI5
ALHEACAAGHTACVH	ASB10	151	Q8WXI3
FKENPNCLPHHHQCF	GSG1	271	Q2KHT4
HCPANVYLHDGHSCQ	ADAM12	501	O43184
KPIIHNAISHCCLAG	CAMSAP1	1476	Q5T5Y3
DCINNVAHVGHCHPG	ETNPPL	51	Q8TBG4
IDCISNVAHVGHCHP	PHYKPL	51	Q8IUZ5
HLNLAGCHRLTDHCL	FBXL19	631	Q6PCT2
CPTGVFHLDVKHNHV	RAG2	41	P55895
KCIHDHHCGSQLSST	NETO1	426	Q8TDF5
HCTNPALCVQPHHIT	NFIB	156	O00712
SHKLSQHCIRICGHL	PAPPA-AS1	36	Q5QFB9
TGSRCEHSQALHCHP	HSPG2	3876	P98160
LHGHKDFHPRVTCAC	RAB34	26	Q9BZG1
LCRSCEHPLADHVSH	KAT2A	146	Q92830
DVNCTHGTLKPLHCA	ASB8	46	Q9H765
KRCPCHLENTHSCHP	MEGF10	366	Q96KG7
FLEHSHCALPTEAQH	FAM189A1	496	O60320
LESCLCSFVHLNHPL	FAM106C	26	P0CH98
CSFVHLNHPLHISDP	FAM106C	31	P0CH98
QQHHHLLHCLEKTTC	KCND1	476	Q9NSA2
EHHAVDIDLYHCPNC	KDM7A	71	Q6ZMT4
HQCIGVCDKHLVNHY	KCTD7	261	Q96MP8
SQNHLHHCPLQICAL	LRRIQ4	311	A6NIV6
THLLDFPHSNHVKSC	HIPK1	521	Q86Z02
PSCLLCNILHHYLHQ	KIAA1109	2101	Q2LD37
CLHLHRALLQHCPAF	KCNH6	581	Q9H252
FCHSHSICHRDLKPE	BRSK2	131	Q8IWQ3
HPNQAHHSLCPAEEL	CCDC120	96	Q96HB5
HVLHHGVCQENCPER	PCSK5	1301	Q92824
LGHKQACAQPDHLDH	PDCD2	166	Q16342
CKGNVLHHSYCLHPD	OR51I1	171	Q9H343
RNHTHGACLVECPSH	MUC2	4751	Q02817
IHHVPGLECHDQTVC	PGLYRP4	81	Q96LB8
HTKGSHCEQCLPLFV	MEGF8	2276	Q7Z7M0
ISSKDCDPQLLHHLC	PI4KA	1201	P42356
IAFPLICAHFVHCTH	NCKAP1L	566	P55160
LHCLHSLAIPCNNVE	LRRK2	226	Q5S007
HSPIHDNINCLHVHC	MANSC4	86	A6NHS7
KVHSQGPHHVCELCN	MAZ	411	P56270
DPHTGQCLRCLHHTE	LAMB2	1001	P55268
QCLRCLHHTEGPHCA	LAMB2	1006	P55268
HCVTHQCEKHQDGLV	MUC5AC	5476	P98088
LPFCGHHVVSHFTCK	OR13J1	166	Q8NGT2
GKQHPIEAHHLSSIC	HECTD4	256	Q9Y4D8
PVQDPQLLHHCQHCD	IKZF5	356	Q9H5V7
GCHPQAQCHHHIIQQ	POF1B	181	Q8WVV4
VACLCLHHLLPDHAP	NLRC5	411	Q86WI3
SHTCAPAGQARCVHH	NID2	856	Q14112
TCAILCHIYHHALHS	EIF3C	566	Q99613
VLHTACALDIKHHCA	GLG1	1066	Q92896
ADAGHVCHLCHPNCT	EGFR	611	P00533
HCDPCGLHFRHKSQL	BCL6B	441	Q8N143
DSTHQLLQPHHDCCQ	BOC	1006	Q9BWV1
LHLPACVTENHHLLF	DOCK6	621	Q96HP0
SDGLCRPCHVHQLLH	LINC00315	116	P59091
GQCHLPIKSHQHCYS	CEP350	2016	Q5VT06
SAQSHVCSHHNQCLP	LYST	756	Q99698
GRKQHHCAPLCLLHF	ALOX12B	331	O75342
HHQVVHTGEKPYCCL	FIZ1	96	Q96SL8
SCHGNVHKLHQFPSL	MARF1	201	Q9Y4F3
HQHHFVTCACLKDVT	CCDC170	686	Q8IYT3
DCEAKVHCSPGHHYN	SCUBE1	736	Q8IWY4
VACHLTHTVPCAHQK	SCAP	1066	Q12770
KINYQLHQHHEPCCR	METTL4	21	Q8N3J2
AHCDVIHQELFAPCH	OTOGL	676	Q3ZCN5
PFCGHHQEINHFLCD	OR10Q1	171	Q8NGQ4
LTVCEDGCRNKLHHH	MAP3K1	456	Q13233
SSPPCEVQALCHHLA	RUSC2	1446	Q8N2Y8
CAQLLHVHEIFLDCH	PHTF2	651	Q8N3S3
EHPCDFTSNVIHKHG	TRIM45	221	Q9H8W5
HSPQKSHQCAHCEKT	PLAGL1	56	Q9UM63
HTENHSPEHKFLCAL	SMYD4	431	Q8IYR2
LCATHLSHQLCQDLP	SSPOP	4441	A2VEC9
QHAVELKPLCGCHSF	SMAD6	236	O43541
LGLACSQHLHSPQHK	NHS	561	Q6T4R5
KHNTAGSHCQHCAPL	NTN4	296	Q9HB63
PINHTDCLVSALHHC	MMP23B	146	O75900
NLGQSLSEPACHCHH	PLEKHG4	681	Q58EX7
LSEPACHCHHAATIA	PLEKHG4	686	Q58EX7
HIHSTVKPFICEVCH	PRDM16	386	Q9HAZ2
HCPKCHLLQEVPHEG	POT1	381	Q9NUX5
CPCHQLDNLSHHFLI	SFRP1	256	Q8N474
HLQTHDPNKEALHCS	PLAGL2	116	Q9UPG8
KNCHHSGSQVPLIHC	RNASE2	96	P10153
AFCHSVLHNPHQTGC	TRAF5	46	O00463
HGEVNIKHYLNCSHC	ALK	976	Q9UM73
CHEALHADVSKCPIH	ANKUB1	231	A6NFN9
EHLVIASFCLKHCQH	NLRP9	576	Q7RTR0
TLHLAQNPFVCDCHL	SLIT3	431	O75094
KCHHGQCHISDQGEP	SLIT3	1416	O75094
AQCHGNFCIQHRHPL	ZFAND2A	116	Q8N6M9
NFCIQHRHPLDHSCR	ZFAND2A	121	Q8N6M9
QQLHNIHKCTIKHCP	TRPS1	551	Q9UHF7
LFKHLHVCAEHAQSP	ZNF414	191	Q96IQ9
EQHVSFKPFRCAHCH	ZFAT	986	Q9P243
ICHLHKQPCHVIYTD	MTREX	296	P42285
GQPLPHHQCSIHLNC	PYROXD2	396	Q8N2H3
HAKNNFTCVACHPTE	WDR75	201	Q8IWA0
VVAENPCQNHHCKHG	SPARC	66	P09486
PCQNHHCKHGKVCEL	SPARC	71	P09486
HDHHFLDPNCHICKD	SPOCD1	781	Q6ZMY3
PQHVLTAAHCVHDGK	PRSS35	161	Q8N3Z0
IHQHTHACPQLSCLH	nan	176	Q6ZSR6
RAQPNHDPNTHHCLC	XRN2	216	Q9H0D6
EICHFLHTCREGNQH	NF1	116	P21359
DCGPTGLAQHCHLHA	STAB1	821	Q9NY15
NACLAPICSLHHVAV	XDH	71	P47989
CLPGHKQVDHHCKDT	USP17L1	176	Q7RTZ2
CHIHAHCLFERNGAV	THBS3	426	P49746
VNFKHPQTHETALHC	TNKS2	356	Q9H2K2
AHGAVLRPCQHHILC	UNKL	646	Q9H9P5
KPCHEHDAFENIVHC	ZNF350	101	Q9GZX5
VHSLTGHDQELTHCC	WDR37	316	Q9Y2I8
GHDQELTHCCTHPTQ	WDR37	321	Q9Y2I8
HHIHTGNKPFKCDEC	ZNF251	256	Q9BRH9
QHQVTHTGQKPCHCS	ZNF251	611	Q9BRH9
LTHQGTRPHKCQVCH	ZNF366	301	Q8N895
IHQESKTHQCLHCDH	ZFX	626	P17010
QHHTCPHCRHNIIEQ	ZNRF3	326	Q9ULT6
ACICPSHLHSHGRTD	ZNF57	176	Q68EA5
SHIQTSHCEVFHKCP	ZNF687	781	Q8N1G0
LVIHTGDKPNHCTLC	ZNF131	411	P52739
YHFLQLHCHPACLVL	ERCC4	46	Q92889
HLHSCDNVKVIAVCH	TBCCD1	371	Q9NVR7
AHEKIHQCPECNFAT	ZNF142	396	P52746
THNCHKHAECIYLGH	THBS2	656	P35442
NFCIKHRHPLDHDCS	ZFAND2B	121	Q8WV99
LGSLHLPPNCVLHCH	TMUB1	156	Q9BVT8
GHLHHGKTCFVDCLI	EFTUD2	136	Q15029
LDLFQGHKTHQCPHC	ZNF711	581	Q9Y462
GHKTHQCPHCDHKST	ZNF711	586	Q9Y462
PIDNHACLCSHDKLH	USP48	506	Q86UV5
IATELPCHHFFHKPC	PJA2	646	O43164
CHDCGKAFQHPSHLK	ZNF317	336	Q96PQ6
SLFSHQKHHVCPECG	ZNF169	226	Q14929
HCHQHKYCDPNLGLR	CD40	76	P25942
AAIHCGHTFHLQCLI	TRAIP	21	Q9BWF2
RQHVCLHAHAHLPFC	GRIN2C	1146	Q14957